Next Article in Journal
Structural Elucidation of 2-(6-(Diethylamino)benzofuran-2-yl)-3-hydroxy-4H-chromen-4-one and Labelling of Mycobacterium aurum Cells
Previous Article in Journal
Synthesis and Structure of N-(1-(Bromomethyl)-7,7-dimethylbicyclo[2.2.1]heptan-2-yl)benzenesulfonamide
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

1-(3-Isoselenocyanatopropyl)adamantane

by
Dmitry Pitushkin
1,
Vladimir Burmistrov
1,2 and
Gennady Butov
1,2,*
1
Department of Organic Chemistry, Volgograd State Technical University, 400005 Volgograd, Russia
2
Department of Chemistry, Technology and Equipment of Chemical Industry, Volzhsky Polytechnic Institute (Branch), Volgograd State Technical University, 404121 Volzhsky, Russia
*
Author to whom correspondence should be addressed.
Molbank 2023, 2023(2), M1646; https://doi.org/10.3390/M1646
Submission received: 27 March 2023 / Revised: 5 May 2023 / Accepted: 11 May 2023 / Published: 15 May 2023
(This article belongs to the Section Organic Synthesis)

Abstract

:
The title compound, 1-(3-isoselenocyanatopropyl)adamantane, was synthesized for the first time from 3-(adamantan-1-yl)propan-1-amine by the two-stage reaction with 1-(3-isocyanopropyl)adamantane as intermediate. The product was characterized by NMR, GC-MS, and elemental analysis.

1. Introduction

Previously, we reported synthesis of adamantane isoselenocyanates containing methylene (1) and 1,2-ethylene (2) spacers between isoselenocyanate (NCSe) group and adamantane fragment [1] and selenoureas (3) based on them [2,3]. Isoselenocyanates and isothiocyanates with lipophilic groups possess anti-cancer activity towards triple-negative breast cancer (TNBC) cells (Figure 1) [4,5]. It was discovered that antiproliferative activity rises with the elongation of the linker between NCSe group and adamantane fragment. 1,3-Disubstituted selenoureas containing adamantane moiety show anti-inflammatory activity through the inhibition of soluble epoxide hydrolase (sEH) [6] and antioxidant activity associated with the ability of selenium to scavenge reactive oxygen species (ROS) [7,8].
This makes the synthesis of new isoselenocyanates with a longer linker between the NCSe group and adamantyl moiety relevant. The present study is aimed at preparation of isoselenocyanate with a 1,3-propylene linker.

2. Results and Discussion

The most challenging step in preparation of isoselenocyanates is a synthesis of isonitrile from amine because of the heterogeneous nature of the reaction between CHCl3 and aqueous NaOH which requires the use of phase transfer catalysts, such as Aliquat 336 or Adogen 464 [9]. Although this approach gives good yields, it is characterized by the complexity of the isolation stage due to contamination of the product by phase transfer catalysts and its fragments. Another common method is based on the formation of formamide from the starting amine, which, in subsequent steps, is dehydrated by treatment with POCl3 or triphosgene [10]. However, POCl3, and, even more so, triphosgene, are highly toxic substances, the handling of which requires special care. At the same time, data on the use of alcohols for the homogenization in the reactions involving CHCl3 and aqueous NaOH is described in the literature. For example, Biddle [11] recommends avoiding the use of ethyl alcohol as a solvent for KOH, and Lindemann [12] reports that without the addition of a small amount of ethyl alcohol, the reaction quickly stops. We investigated a range of alcohols, methanol, ethanol, isopropanol, tert-butanol, and 1-octanol, as replacements for the Aliquat 336 phase transfer catalyst. The best results have been achieved with tert-butanol [13]. By excluding water from the reaction, and using dry alkali, it was possible to increase the yield of isonitrile up to 88% (Table 1).
We have carried out the synthesis of compound 5 in a mixture of methylene chloride and tert-butyl alcohol without the use of phase transfer catalysts (Scheme 1).
Synthesized at the first stage, 1-(3-isocyanopropyl)adamantane (5) has a characteristic signal in the 1H NMR spectrum. The signal of CH2-NC is triplet of triplets at 3.36 ppm with J = 6.8 and 1.9 Hz (Figure S5). Spin–spin interaction between carbon-13 (13C) and nitrogen-14 (14N) in isonitriles can result in the splitting of carbon signals into triplets with an intensity distribution of 1:1:1. This occurs due to the symmetric distribution of electrons in the nitrogen atom, which leads to the formation of two spin states with equal energy, created when the nuclear spin of 14N is oriented parallel and perpendicular to the magnetic field. Quantum transitions between these states lead to an effective spin–spin interaction between carbon and nitrogen, resulting in the splitting of carbon signals into three lines with an intensity ratio of 1:1:1. However, in some cases, due to the low concentration of isonitriles, this effect may be weak or not observed at all [14,15]. In the 13C NMR spectrum, CH2-NC is a singlet at 69.16 ppm. Compound 5 was washed with water to separate tert-butyl alcohol and NaOH, and with 1 N HCl to remove unreacted amine 4.
The synthesis of isoselenocyanate from isonitrile through the addition of elemental selenium occurs in a basic medium (Et3N) at room temperature [16]. Crude compound 6 could then be isolated with 84% yield (GC-MS) by filtration of the excess of selenium and evaporation of the solvent.

3. Materials and Methods

1H and 13C NMR spectra were taken with a Bruker DPX 300 machine (Bruker AXS Handheld Inc., Kennewick, WA, USA) (at frequencies of 300 and 75 MHz) in CDCl3 solution with TMS as the standard. J values are given in Hz. The GC-MS spectrum was measured on an Agilent GC5975/MSD 7820 (Agilent Technologies, Santa Clara, CA, USA) using electron impact ionization (EI). Chromatographic separation was performed in splitless mode on an HP-5MS quartz capillary column (30 m × 0.25 mm × 0.5 μm film thickness) in the programmed temperature mode (from 80 to 280 °C, 10 °C/min), with carrier gas helium (1 mL/min), and at an injector temperature of 250 °C. The elemental analysis was performed on a PerkinElmer Series II 2400 Elemental Analyzer (PerkinElmer Inc., Waltham, MA, USA). The TLC analysis was carried out on Merck silica gel chromatography plates with fluorescent indicator F254 (1.05554); sorbent: Silica 60, layer thickness 200 um; pore size 60 Å, particle size 10–12 um; and binder: organic polymer (Merck KGaA, Darmstadt, Germany). Flash chromatography was performed on Buchi Pure C-815 Flash (Büchi Labortechnik AG, Flawil, Switzerland). The solvents and reagents were purchased from commercial sources. 3-(Adamantan-1-yl)propan-1-amine was synthesized by known methods from 1-bromoadamantane through the 3-(adamantan-1-yl)propanenitrile as intermediate [17,18].
Into a flat-bottom flask were added 364 mg (1.88 mmol, 1 eq.) of 3-(adamantan-1-yl)propan-1-amine, 5 mL of t-BuOH, 2.5 mL of DCM, and 301 mg (7.53 mmol, 4 eq.) of finely ground NaOH. After that, 258 mg (2.16 mmol, 1,15 eq.) of CHCl3 was dissolved with 2.5 mL of DCM and added dropwise to the mixture described above with stirring. Resulting reaction mass was left stirred for 1.5 h at room temperature. After that, reaction mass was refluxed with stirring for 8 h. After cooling to room temperature, 5 mL of DCM and 5 mL of H2O were added. The organic layer was separated, washed with 1 N HCl, and dried with Na2SO4. Solvent was removed in vacuo to give 338 mg (88% yield) of crude 1-(3-isocyanopropyl)adamantane (5, Figure 2) as yellow oil which was used further without purification. Mass spectrum, m/z (Irel. %): 202 (50% [M − 1]+), 188 (41% [M-CSe]+), 175 (48% [M-NCSe]+), 160 (19% [M-CH2NCSe]+), 146 (30% [Ad − CH2]+), 135 (100% [Ad]+), retention time = 13.583 min. 1H NMR (300 MHz, CDCl3), δ, ppm: 1.15–1.21 (m, 2H, H11), 1.46 (d, J = 2.9 Hz, 6H, H2, H8, H9), 1.60–1.76 (m, 8H, H4, H6, H10, H12), 1.88–1.99 (m, 3H, H3, H5, H7), 3.36 (tt, J = 6.8, 1.9 Hz, 2H, H13). 13C NMR (75 MHz, CDCl3), δ, ppm: 22.85 (C12), 28.61 (C3, C5, C7), 31.94 (C1), 37.09 (C4, C6, C10), 41.13 (C11), 42.31 (C2, C8, C9), 69.16 (C13). Calc. for C14H21N: C 82.70; H 10.41; N 6.89. Found: C 82.73; H 7.54.; N 4.95. M = 203.33.
To the 338 mg (1.66 mmol, 1 eq.) of crude 1-(3-isocyanopropyl)adamantane (5) dissolved in 10 mL of THF were added 197 mg (2.49 mmol, 1,5 eq.) of elemental selenium and 252 uL (2.49 mmol, 1,5 eq.) of Et3N. Reaction mass was stirred for 8 h at room temperature. The excess of selenium was separated by suction filtration and filtrate was concentrated on a rotary evaporator. The resulting crude 1-(3-isoselenocyanatopropyl)adamantane (6, Figure 3) was purified with flash chromatography (EA-hexane, 19-1, v/v). Pure 1-(3-isoselenocyanatopropyl)adamantane (6): 112 mg, 0.43 mmol, 24% yield, pale yellow oil. Mass spectrum, m/z (Irel. %): 283 (18% [M + 1]+), 202 (9% [M − Se]+), 135 (100% [Ad]+), retention time = 18.239 min. 1H NMR (300 MHz, CDCl3), δ, ppm: 1.11–1.23 (m, 2H, H11), 1.50 (d, J = 2.9 Hz, 6H, H2, H8, H9), 1.59–1.80 (m, 8H, H4, H6, H10, H12), 2.03–1.95 (m, 3H, H3, H5, H7), 3.58 (t, J = 6.8 Hz, 2H, H13). 13C NMR (DMSO-d6), δ, ppm: 23.22 (C12), 28.62 (C3, C5, C7), 32.08 (C1), 37.07 (C4, C6, C10), 41.25 (C11), 42.30 (C2, C8, C9), 46.40 (C13). Calc. for C14H21NSe: C 59.57; H 7.50; N 4.96. Found: 59.60; H 7.54.; N 4.95. M = 282.29.

4. Conclusions

In this work, we presented the previously unknown compound 1-(3-isoselenocyanatopropyl)adamantane, which was synthesized for the first time from 3-(adamantan-1-yl)propan-1-amine by the two-stage reaction.

Supplementary Materials

The following supporting information can be downloaded online, 1H NMR, 13C NMR and Mass spectra; Figure S1: Chromatogram of compound 5; Figure S2: Mass spectrum of compound 5; Figure S3: NMR 1H of compound 5; Figure S4: Fragment of the NMR 1H spectrum of compound 5 with tt of CH2-NC; Figure S5: NMR 13C of compound 5; Figure S6: Chromatogram of compound 6; Figure S7: Mass spectrum of compound 6; Figure S8: NMR 1H of compound 6; and Figure S9: NMR 13C of compound 6.

Author Contributions

Conceptualization, V.B.; investigation, D.P., V.B.; writing, review, and editing, V.B.; project administration, G.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research was performed with financial support from the Russian Science Foundation (project no. 22-73-00297).

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Burmistrov, V.V.; Pitushkin, D.A.; Vasipov, V.V.; D’yachenko, V.S.; Butov, G.M. Synthesis of 3-adamantylated hydantoins and their 2-thio(seleno) analogs. Chem. Heterocycl. Comp. 2019, 55, 619–622. [Google Scholar] [CrossRef]
  2. Kuznetsov, Y.P.; Rasskazova, E.V.; Pitushkin, D.A.; Eshtukov, A.V.; Vasipov, V.V.; Burmistrov, V.V.; Butov, G.M. Synthesis and Properties of N,N′-Disubstituted Ureas and Their Isosteric Analogs Containing Polycyclic Fragments: XI. 1-[(Adamantan-1-yl)alkyl]-3-arylselenoureas. Russ. J. Org. Chem. 2021, 57, 1036–1046. [Google Scholar] [CrossRef]
  3. Kuznetsov, Y.P.; Pitushkin, D.A.; Burmistrov, V.V.; Butov, G.M. Synthesis and Properties of N,N′-Disubstituted Ureas and Their Isosteric Analogs Containing Polycyclic Fragments: XV. N,N′-(Alkane-α,ω-diyl)bis[N′-(adamantan-1-yl)]selenoureas. Russ. J. Org. Chem. 2022, 58, 1398–1402. [Google Scholar] [CrossRef]
  4. Burmistrov, V.; Saxena, R.; Pitushkin, D.; Butov, G.M.; Chung, F.-L.; Aggarwal, M. Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure−Activity Relationships. J. Med. Chem. 2021, 64, 6621–6633. [Google Scholar] [CrossRef] [PubMed]
  5. Aggarwal, M.; Saxena, R.; Sinclair, E.; Fu, Y.; Jacobs, A.; Dyba, M.; Wang, X.; Cruz, I.; Berry, D.; Kallakury, B.; et al. Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth. Cell Death Differ. 2016, 23, 1615–1627. [Google Scholar] [CrossRef] [PubMed]
  6. Burmistrov, V.; Morisseau, C.; Babkov, D.A.; Golubeva, T.; Pitushkin, D.; Sokolova, E.V.; Vasipov, V.; Kuznetsov, Y.; Bazhenov, S.V.; Novoyatlova, U.S.; et al. Anti-Inflammatory Activity of Soluble Epoxide Hydrolase Inhibitors Based on Selenoureas Bearing an Adamantane Moiety. Int. J. Mol. Sci. 2022, 23, 10710. [Google Scholar] [CrossRef] [PubMed]
  7. Hou, W.; Dong, H.; Zhang, X.; Wang, Y.; Su, L.; Xu, H. Selenium as an emerging versatile player in heterocycles and natural products modification. Drug Discov. Today 2022, 27, 2268–2277. [Google Scholar] [CrossRef] [PubMed]
  8. Calvo-Martin, G.; Plano, D.; Encio, I.; Sanmatrin, C. Novel N,N′–Disubstituted Selenoureas as Potential Antioxidant and Cytotoxic Agents. Antioxidants 2021, 10, 777. [Google Scholar] [CrossRef] [PubMed]
  9. Zakrzewski, J.; Huras, B.; Kiełczewska, A.; Krawczyk, M.; Hupko, J.; Jaszczuk, K. Reactions of Nitroxides, Part 17. Synthesis, Fungistatic and Bacteriostatic Activity of Novel Five- and Six-Membered Nitroxyl Selenoureas and Selenocarbamates. Molecules 2019, 24, 2457. [Google Scholar] [CrossRef] [PubMed]
  10. Salami, S.A.; Siwe-Noundou, X.; Krause, R.W.M. A More Sustainable Isocyanide Synthesis from N-Substituted Formamides Using Phosphorus Oxychloride in the Presence of Triethylamine as Solvent. Molecules 2022, 27, 6850. [Google Scholar] [CrossRef] [PubMed]
  11. Biddle, H.C. Ueber Derivate des Isuretins der Formhydroxamsäure und ihre Beziehungen zur Knallsäure. Eur. J. Org. Chem. 1900, 310, 1–24. [Google Scholar] [CrossRef]
  12. Lindemann, H.; Wiegrebe, L. Über die Konstitution der Verbindungen mit “zweiwertigem” Kohlenstoff. Chem. Ber. 1930, 63, 1650–1657. [Google Scholar] [CrossRef]
  13. Kuznetsov, Y.P.; Pitushkin, D.A.; Eshtukova-Shcheglova, E.A.; Burmistrov, V.V.; Butov, G.M.; Novakov, I.A. Synthesis and antioxidant activity of 1-R-3-(2-fluorophenyl)selenoureas containing polycyclic fragments. Russ. Chem. Bull. 2022, 71, 2467–2472. [Google Scholar] [CrossRef]
  14. McCullough, C.R.; Pullela, P.K.; Im, S.-C.; Waskell, L.; Sem, D.S. 13C-Methyl isocyanide as an NMR probe for cytochrome P450 active sites. J. Biomol. NMR 2009, 43, 171–178. [Google Scholar] [CrossRef] [PubMed]
  15. Nichugovskiy, A.I.; Khrulev, A.A.; Perevoshchikova, K.A.; Cheshkov, D.A.; Morozova, N.G.; Maslov, M.A. Synthesis of Isonitrile Derivatives of Diglycerides and Carbohydrates as Intermediates for Multicomponent Ugi Reaction. Russ. J. Bioorg. Chem. 2021, 47, 929–938. [Google Scholar] [CrossRef]
  16. Ivanenkov, Y.A.; Veselov, M.S.; Rezekin, I.G.; Skvortsov, D.A.; Sandulenko, Y.B.; Polyakova, M.V.; Bezrukov, D.S.; Vasilevsky, S.V.; Kukushkin, M.E.; Moiseeva, A.A.; et al. Synthesis, isomerization and biological activity of novel 2-selenohydantoin derivatives. Bioorg. Med. Chem. 2016, 24, 802–811. [Google Scholar] [CrossRef] [PubMed]
  17. Tanaka, K.; Hiraoka, T.; Ishiguro, F.; Jeona, J.-H.; Chujo, Y. Adamantane ionic liquids. RSC Adv. 2014, 4, 28107–28110. [Google Scholar] [CrossRef]
  18. Novakov, I.A.; Kulev, I.A.; Radchenko, S.S.; Birzniens, K.A.; Boreiko, E.I.; Vladyko, G.V.; Korobchenko, L.V. Synthesis and antiviral activity of the hydrochlorides of alicyclic mono- and diamines. Pharm Chem. J. 1987, 21, 287–291. [Google Scholar] [CrossRef]
Figure 1. Bioactive adamantane compounds containing selenium. 1-(Isoselenocyanatomethyl)adamantane (1), 1-(2-isoselenocyanatoethyl)adamantine (2), and 1-(2-(adamantan-1-yl)ethyl)-3-benzylselenourea (3).
Figure 1. Bioactive adamantane compounds containing selenium. 1-(Isoselenocyanatomethyl)adamantane (1), 1-(2-isoselenocyanatoethyl)adamantine (2), and 1-(2-(adamantan-1-yl)ethyl)-3-benzylselenourea (3).
Molbank 2023 m1646 g001
Scheme 1. Synthesis of 1-(3-isoselenocyanatopropyl)adamantane (6) from 3-(adamantan-1-yl)propan-1-amine (4).
Scheme 1. Synthesis of 1-(3-isoselenocyanatopropyl)adamantane (6) from 3-(adamantan-1-yl)propan-1-amine (4).
Molbank 2023 m1646 sch001
Figure 2. Carbon atoms labelling for compound 5.
Figure 2. Carbon atoms labelling for compound 5.
Molbank 2023 m1646 g002
Figure 3. Carbon atoms labelling for compound 6.
Figure 3. Carbon atoms labelling for compound 6.
Molbank 2023 m1646 g003
Table 1. Yield of compound 5 using alcohol as a substitute for Aliquat 336 phase transfer catalyst.
Table 1. Yield of compound 5 using alcohol as a substitute for Aliquat 336 phase transfer catalyst.
AlcoholTime, hThe Content of Compound 5
in the Reaction Mass, %
methanol823
ethanol849
i-propanol865
tert-butanol888
1-octanol851
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Pitushkin, D.; Burmistrov, V.; Butov, G. 1-(3-Isoselenocyanatopropyl)adamantane. Molbank 2023, 2023, M1646. https://doi.org/10.3390/M1646

AMA Style

Pitushkin D, Burmistrov V, Butov G. 1-(3-Isoselenocyanatopropyl)adamantane. Molbank. 2023; 2023(2):M1646. https://doi.org/10.3390/M1646

Chicago/Turabian Style

Pitushkin, Dmitry, Vladimir Burmistrov, and Gennady Butov. 2023. "1-(3-Isoselenocyanatopropyl)adamantane" Molbank 2023, no. 2: M1646. https://doi.org/10.3390/M1646

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop